Roelof M. L. Rongen,Robert A. Shalwitz,Douglas Kling,Ralph T. Doyle, Jr.
申请号：
US12561558
公开号：
US08871800B2
申请日:
2009.09.17
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Methods of utilizing a combined administration or a unit dosage of a combination of an HMG-CoA inhibitor and omega-3 fatty acids for the reduction of apolipoprotein-B levels. The methods are especially useful in the treatment of patients with hypertriglyceridemia or hypercholesterolemia or mixed dyslipidemia, coronary heart disease (CHD), vascular disease, atherosclerotic disease and related conditions, and for the prevention or reduction of cardiovascular, cardiac, and vascular events.
